| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net patient revenues | $1.47B+17.4% | $1.25B+15.1% | $1.09B+5.7% | $1.03B+6.6% | $965.5M |
| Other revenues | $48.1M+4.3% | $46.2M-14.4% | $53.9M+19.3% | $45.2M-0.4% | $45.4M |
| Government stimulus income | $0-100.0% | $9.4M | $0-100.0% | $11.5M-81.9% | $63.4M |
| Net operating revenues and stimulus income | $1.52B+16.1% | $1.31B+14.5% | $1.14B+5.1% | $1.09B+1.1% | $1.07B |
| Salaries, wages and benefits | $921.1M+13.6% | $810.9M+13.8% | $712.3M+3.8% | $686.2M+3.0% | $666.1M |
| Other operating | $377.2M+17.4% | $321.4M+11.5% | $288.2M-0.4% | $289.4M+8.5% | $266.8M |
| Facility rent | $46.2M+7.1% | $43.2M+4.0% | $41.5M+1.3% | $41.0M+0.4% | $40.8M |
| Depreciation and amortization | $44.9M+7.0% | $42.0M-0.1% | $42.0M+3.8% | $40.5M-0.4% | $40.7M |
| Total costs and expenses | $1.39B+14.1% | $1.22B+12.3% | $1.08B+2.9% | $1.05B+3.0% | $1.02B |
| Income from operations | $128.4M+42.8% | $89.9M+56.5% | $57.5M+80.1% | $31.9M-37.4% | $50.9M |
| Non-operating income | $18.1M-8.0% | $19.7M+18.2% | $16.7M+49.5% | $11.1M-37.3% | $17.8M |
| Interest expense | -$6.4M-54.1% | -$4.1M-1176.2% | -$324K | — | — |
| Unrealized gains on marketable equity securities | $22.3M-27.8% | $31.0M+107.2% | $14.9M+194.5% | -$15.8M-14.0% | -$13.9M |
| Income before income taxes | $162.4M+19.1% | $136.4M+53.7% | $88.7M+225.9% | $27.2M-81.9% | $150.0M |
| Income tax provision | -$39.8M-16.0% | -$34.3M-46.4% | -$23.4M-223.3% | -$7.3M+33.8% | -$11.0M |
| Net income | $122.6M+20.1% | $102.1M+56.4% | $65.3M+226.8% | $20.0M-85.6% | $139.1M |
| Net (income) loss attributable to noncontrolling interest | -$2.6M-1529.6% | -$159K-110.5% | $1.5M-38.8% | $2.5M+596.6% | -$497K |
| Net income attributable to National HealthCare Corporation | $120.0M+17.7% | $101.9M+52.6% | $66.8M+197.6% | $22.4M-83.8% | $138.6M |
| Basic (in dollars per share) | $7.76+17.2% | $6.62+51.8% | $4.36+198.6% | $1.46-83.8% | $9.03 |
| Diluted (in dollars per share) | $7.67+17.5% | $6.53+50.5% | $4.34+199.3% | $1.45-83.9% | $8.99 |
| Basic (in shares) | 15.5M+0.5% | 15.4M+0.5% | 15.3M-0.6% | 15.4M+0.4% | 15.3M |
| Diluted (in shares) | 15.6M+0.3% | 15.6M+1.4% | 15.4M-0.5% | 15.4M+0.2% | 15.4M |
| Dividends declared per common share (in dollars per share) | $2.53+4.5% | $2.42+3.4% | $2.34+3.5% | $2.26+7.1% | $2.11 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.